Clinical Trials Logo

Clinical Trial Summary

The study evaluates the immunogenicity, safety and tolerability of V501 in preadolescent females


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00411749
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase Phase 2
Start date December 2006
Completion date September 2009

See also
  Status Clinical Trial Phase
Completed NCT00956553 - Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls Phase 4
Completed NCT05372016 - Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Recruiting NCT05027776 - Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years Phase 3
Suspended NCT00733122 - Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034) Phase 3
Recruiting NCT04895020 - Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years Phase 3
Recruiting NCT05371353 - Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Completed NCT03900572 - A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine Phase 1
Completed NCT00635830 - An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) Phase 1
Not yet recruiting NCT01021904 - Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China Phase 4
Completed NCT00378560 - V501 Efficacy Study in Women Aged 18 to 26 (V501-027) Phase 2
Completed NCT00682812 - Significance of the High-risk Hpv Viral Load N/A
Completed NCT01086709 - Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Completed NCT00711815 - A Study to Identify Markers in Blood and Tissue of HPV Clearance N/A
Completed NCT00834106 - Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) Phase 3
Completed NCT03085381 - A Phase I Study of Quadrivalent HPV Recombinant Vaccine Phase 1
Completed NCT00847340 - Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population N/A
Completed NCT00943722 - A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) Phase 3